“…However, attempts to reduce the residual renal damage in experimental ARF with propranolol [5,10], chronic saline loading [II], infusion of angiotensin antagonist or the vasodilating prostaglandin A, have so far met with partial or no success [5,13]. Furthermore, in most experimental studies, treatment was instituted prior to or concurrently with the induction of renal ischemia, while in a clinical setting one should look for treatment modalities effective when employed some time after the occurrence of the ischemic event.…”